Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VLA15 (Lyme Borreliosis Vaccine) Phase 2 Study
NCT03970733Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jul 2019
- Primary completion
- Apr 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of VLA15 in Lyme disease, sponsored by Pfizer. Started Jul 2019; status: completed.
02
Drugs
VLA15
03
Conditions
Lyme disease
Beyond the preview
Go deeper on NCT03970733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03970733.